MedCity News February 2, 2023
Marissa Plescia

New York healthcare startups received $3.9 billion of funding in 2022, compared to $9 billion in 2021, according to a new DHNY report. Biotech startups represented 22% of total funding in 2022, a stark difference from women’s health only representing 2%.

Last year, healthcare funding in the New York metropolitan area showed a steep decline to $3.9 billion among 141 companies from $9 billion among 182 companies in 2021, a new report shows. Biotech companies saw the most interest, whereas investment in women’s health appears to have fallen off a cliff.

The annual report — New York Healthcare Innovation Report — was published Wednesday by Digital Health New York (DHNY), a network of CEOs, founders, investors, payers and providers in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Digital Health, Investments, Pharma / Biotech, Survey / Study, Technology, Trends
Openstream.ai notches patent for multimodal AI-driven digital twin
Fierce Fundraising Tracker—Tennr nabs $18M to fix fax problem
March Fundraising Roundup: 7 Provider Tech Startups That Closed Rounds This Month
Pelago Defies Digital Health Funding Drought, Raises $58M
Digital health venture capital deals stagnate

Share This Article